Charles River Laboratories International, Inc.
CRL ✓ COMPLIANTFree checks used up today ☆ Track — members
NYSE
·
Healthcare
·
Biotechnology & Medical Research
·
Last Close
$344.87
▲ +9.33%
Price charts are for members
Interactive price history from intraday to 5 years, on every stock and ETF.
See plans
Key Metrics
P/E Ratio
N/A
FWD: 27.63
Market Cap
$16.46B
Large Cap
Div Yield
N/A
N/A
EPS Growth
+10.64%
YoY
RSI (14)
78.53
Momentum
Beta
1.40
vs Market
52W High
$348.91
5.16% below
52W Low
$146.33
115.57% above
Volume
548.94K
Avg 289.25K
P/B
3.17
Price-to-book
ROE
15.56%
Return on equity
Free Float
99.21%
Public shares
Historical Returns
5D
+14.20%
1M
+23.60%
3M
+57.19%
6M
+88.35%
YTD
+72.88%
1Y
+83.19%
3Y
+86.00%
5Y
-17.34%
Financials & Valuation
TTM · Annual
| Total Revenue | $4.02B |
| Net Income | $-142,163,000.00 |
| Revenue Growth (YoY) | -2.72% |
| Gross Margin | 30.52% |
| Operating Margin | 12.51% |
| Net Profit Margin | -3.54% |
| ROE | 15.56% |
| ROA · ROIC | -1.36% · N/A |
| P/E Ratio | N/A |
| Forward P/E (FY1) | 27.63 |
| PEG Ratio | N/A |
| P/S | 2.51 |
| P/B | 3.17 |
| P/FCF | 19.47 |
| EPS Growth | +10.64% |
| Outstanding Shares | 47.74M |
Technical Indicators
| 50-Day SMA | $291.56 |
| 200-Day SMA | $216.85 |
| RSI (14) | 78.53 |
| Beta | 1.40 |
| 52-Week High | $348.91 |
| 52-Week Low | $146.33 |
| Volume Today | 548.94K |
| Avg Daily Volume (30D) | 289.25K |
| Relative Volume | 1.90x |
| Volatility (10D) | 48.88 |
| Volatility (30D) | 43.99 |
| Free Float | 99.21% |
